Dynamic Expands to Loudoun County, Virginia — Meeting Customer Demand for Secure, Sustainable ITAD and Data Center Services in “Data Center Alley” 
Prompt Infrastructure as the New Battleground for AI Assistants 
Building Real Software Supply Chain Resilience in a Time of Rising Pressure Immatics Announces Third Quarter 2021 Financial Results and Provides Business Update
Interim data update at SITC for ongoing ACTengine® IMA203 trial targeting PRAME demonstrated clinical responses…
Voyager Therapeutics to Present Preclinical Data from Vectorized Antibody Program at the 26th Society for Neuro-Oncology Annual Meeting
CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene…
Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia
Positive trend observed in transfusion-dependent subjects treated with higher dose tovinontrine for reduced transfusion burden Tovinontrine…
ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC
ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional Facilities Under Construction…
AIM ImmunoTech Provides Third Quarter 2021 Business Update
OCALA, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) announces…
Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at the American Heart Association Scientific Sessions 2021
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32%…
PolyPid Appoints New Oncology Advisory Board Member
Company is Scheduled to Conduct Pre-IND Meeting with the U.S. FDA Later This Month and Potentially Initiate…
MediWound Reports Third Quarter 2021 Financial Results
Third Quarter Revenues of $6.4 Million; Year-to-Date 2021 Revenues Increased 21% Clarity on Regulatory Pathway…
IN8bio Appoints Trishna Goswami, M.D. as Chief Medical Officer
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
First Wave BioPharma Announces Restructuring of Merger Consideration Payment Terms With Former Shareholders of First Wave Bio
BOCA RATON, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI), (“First…
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
WALTHAM, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company…
Codiak Reports Positive Initial Data for exoSTING™ Phase 1/2 Trial Indicating Tolerability, Immune Activation, and Evidence of Tumor Shrinkage in Injected and Non-Injected Tumors in the First Three Dose Escalation Cohorts
– exoSTING resulted in localized STING pathway activation and dose-dependent immune activation – – Intratumoral…
Loos, France, Isovital Headquarter, Nov 16th 2021 – Radiopharma Logistics Group (RLG); ISOVITAL BECOMES CERTIFIED “COMPETENT ORGANISM IN RADIOPROTECTION” (OCR) !Â
Nuclear Medicine/ Radiopharmaceutical/LogisticLoos, France, Isovital Headquarter, Nov 16th 2021Â –Â Radiopharma Logistics Group (RLG); ISOVITAL BECOMES CERTIFIED…
Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant
TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
CytoDyn Submits the First of Three Main Sections of HIV BLA to FDA Under Previously Authorized Rolling Review
Second portion out of three major portions of BLA (CMC portion) will be submitted shortly…
Cend Therapeutics Announces First Patient Dosing in Clinical Trial of CEND-1 for the Treatment of Selected Gastrointestinal Cancers
SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — Patient dosing has begun in a Phase…
Mannheim to Acquire Domino Network for $45 Million
New York, New York–(Newsfile Corp. – November 16, 2021) – Mannheim today announced that it…
JZZ Technologies, Inc. Joins with GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp. to Create New Bioscience Products Company Focused on Breakthrough Therapeutic Products and Research
Working with respected bioscience companies GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp., JZZ Technologies, Inc….
Defense Technologies International Corp. (DTII) City of Myrtle Beach, South Carolina Approves Passive Portal
Del Mar, California–(Newsfile Corp. – November 16, 2021) – Defense Technologies International Corp. (OTC Pink:…
Quoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline
New York, New York–(Newsfile Corp. – November 16, 2021) – PCG Digital — Following a…